Emerging studies highlights the potential of cellular peptides and dual agonists to revolutionize therapeutic strategies for metabolic diseases. These advanced compounds offer the unique capacity to simultaneously activate multiple targets, circumventing the limitations of traditional mono-therapy treatments. By fine-tuning tissue signaling, the… Read More